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Induction of osteoblast differentiation markers in human dermal fibroblasts:
potential application to bone tissue engineering.
Abstract
Tissue engineered constructs have the potential to be used as replacements for current bone graft
technologies. One component necessary for bone tissue engineering is a readily available, osteogenic cell
source. Human dermal fibroblasts may have the potential to differentiate along an osteoblastic lineage,
making them a candidate for use in bone tissue engineering applications. The objective of this study was
to validate the ability of dermal fibroblasts to express gene and protein markers of osteoblastic
differentiation and to explore their potential, in combination with biomaterial scaffolds and signaling
factors, for use in bone tissue engineering.
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Induction of Osteoblast Differentiation Markers in Human Dermal
Fibroblasts: Potential Application to Bone Tissue Engineering
Christopher K. Hee and Steven B. Nicoll
Abstract-Tissue engineered constructs have the potential to
be used as replacements for current bone graft technologies.
One component necessary for bone tissue engineering is a
readily available, osteogenic cell source. Human dermal
fibroblasts may have the potential to differentiate along an
osteoblastic lineage, making them a candidate for use in bone
tissue engineering applications. The objective of this study was
to validate the ability of dermal fibroblasts to express gene and
protein markers of osteoblastic differentiation and to explore
their potential, in combination with biomaterial scaffolds and
signaling factors, for use in bone tissue engineering.

T

I. INTRODUCTION

HERE are over 600,000 bone graft procedures
performed in the United States each year[ 11. Autografts
are used in approximately 90 percent of these surgeries, with
natural and synthetic scaffolds accounting for the remaining
10 percent[2]. While these methods are suitable for use in
bone graft procedures, there are inherent limitations to their
use, including limited supply, disease transmission, and
inferior mechanical and biological properties.
Bone tissue engineering using a combination of an
osteogenic cell source, a biomaterial scaffold, and growth
factors has the potential as a replacement for current graft
materials[3]. Native osteoblasts are typically difficult to
isolate and expand in vitro, which makes them less than
ideal for bone tissue engineering applications[4]. One
potential alternative source of cells that is nonimmunogenic, easily expandable, and readily available
through a minimally invasive harvesting procedure are
dermal fibroblasts. Osteoinduction was first described by
Marshall Urist as the ability of demineralized bone matrix to
induce the osteoblastic differentiation of host fibroblasts[5].
Additionally the potential of fibroblasts to differentiate
towards an osteoblastic lineage have been investigated[6111.
The objective of the following studies was to investigate
the potential of human dermal fibroblasts, in combination
with la,25-dihydroxyvitamin D3, as a source of cells for
bone tissue engineering applications.
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11. MATERIALS
AND METHODS

A . Cell Culture
Neonatal human dermal fibroblasts (Cascade Biologics,
Portland, OR) were maintained in basal medium consisting
of minimum essential medium (MEM) containing 10% fetal
bovine serum (FBS), 100 U/ml penicillin, 100 pg/ml
streptomycin, and 0.075% sodium bicarbonate and
incubated at 37" C with 5% C02.
1) Vitamin D Dose Dependence: Neonatal fibroblasts were
plated at a density of 4500 cells/cm2 in 100-mm dishes in
basal medium containing 1, 10, 100, and 1000 nM la,25dihydroxyvitamin D3 (vitamin D) with 10 mM pglycerophosphate (PGP) and 50 pgiml L-ascorbic acid.
DMSO (0.02%) was added as a vehicle control. Alkaline
phosphatase activity was quantified at 14 days. All further
studies used 100 nM vitamin D.
2) Monolayer Culture: Neonatal fibroblasts were
trypsinized and plated on 100 mm dishes at a seeding
density of 4500 cell/cm2 in basal serum-containing medium
(S medium). Experimental cultures were plated in basal
medium containing 100 nM vitamin D, 10 mM PGP, and 50
pg/ml L-ascorbic acid (S+vitD medium). After 24 hours, all
cultures were rinsed thoroughly with phosphate buffered
saline (PBS) and the medium was replaced with chemicallydefined medium in which 1% insulin-transferrin-selenium
(ITS) was substituted for serum (I and I+vitD medium).
Fibroblast controls were maintained in S and S+vitD
medium. Samples were analyzed at 7, 14, and 21 days for
gene expression, biochemistry, and histology.
3) Bone Morphogenetic Protein (BMP) Signaling: Cells
were plated at a cell density of 10,000 celldm1 in 24 well
plates in S or S+vitD medium. The recombinant BMP
antagonist, noggin (R&D Systems, Minneapolis, MN), was
added at a concentration of 0.1 pgiml to additional cultures
maintained in S+vitD medium. After 24 hours, cultures were
rinsed with PBS and experimental cultures were maintained
in I+vitD medium with or without 0.1 pg/ml Noggin.
Control cultures were maintained in S medium. At 3 and 14
days, samples were taken for analysis of gene expression
and biochemistry.
4) Three-Dimensional Culture Seeding Densig: Dermal
fibroblasts were seeded on 9-mm diameter, 3-mm thick
ultraporous p-tricalcium phosphate (PTCP) scaffolds
(Vitoss, Orthovita, Malvern, PA) at densities of 0.5, 1.5, 3.0,
and 5.0 million cells/scaffold in 70 pl of S medium. Cells
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were allowed to attach for 20 minutes and then flooded with
either S or S+vitD medium. After 24 hours, scaffolds were
rinsed with PBS and maintained in S, S+vitD, I, or I+vitD
medium. Constructs were analyzed at 7, 14, 21, and 28 days
for gene expression, biochemistry, and histology and
immunochemistry.
B. Gene Expression

Total cellular RNA was extracted using the TRIzol
isolation system (Invitrogen). Reverse transcription was
performed using the Superscript First-Strand synthesis
system for RT-PCR. Polymerase chain reactions for the
monolayer study were carried out using TAQ DNA
polymerase and oligonucleotide primers for human alkaline
phosphatase[12], osteocalcin, osteopontin [ 111, and pActin[ 131. PCR products were resolved on a 1% agarose gel
and analyzed by densitometry using Scion Image (Scion
Corporation, Frederick, MD). Real-time PCR was performed
in the BMP signaling and three-dimensional density
dependence studies. Primers for alkaline phosphatase were
as published[ 141. Osteocalcin primers and probes were
purchased as a TAQMAN gene expression assay
(Hs01587813-g1, Applied Biosystems) and BMP6 and
GAPDH primers and probes were designed with Primer
Express 3 .O software (Applied Biosystems). Real-time PCR
reactions were performed with SYBR Green Master Mix or
TAQMAN Master Mix (Applied Biosystems) using an
Applied Biosystems 7300 real-time PCR system. Relative
gene expression was determined using the AAC, method
(Applied Biosystems User Bulletin #2).
C. Biochemistry
Protein and DNA were extracted with a 0.5% Triton-X
100 in PBS. Samples cultured on P-TCP scaffolds required
further extraction of DNA using 0.48 M sodium phosphate.
Alkaline phosphatase activity was determined using a
colorimetric assay (Sigma) in which p-nitrophenyl
phosphate is cleaved to p-nitrophenol. The absorbance of the
resulting product was read at 400 nm on a Biotek Synergy
HT multidetection reader.
Total DNA content was measured using the PicoGreen
double-stranded DNA assay adapted for use in a microplate
reader[l5].
D. Histology and Immunohistochemistry
Samples were fixed with 10% neutral buffered formalin or
4% paraformaldehyde. Three-dimensional scaffolds were
dehydrated and embedded in paraffin. Serial 7-pm thick
sections
were
processed
for
histological
and
Immunohistochemical analysis. Active alkaline phosphatase
was localized by staining for 30 minutes with a Fast Blue
RR-salt and Naphthol AS-MX phosphate dye (Sigma).
Alexa Fluor 488-conjugated phalloidin (Molecular Probes)
at a concentration of 5 unitdm1 was used to stain F-actin.
Polyclonal antibodies for osteocalcin (V-19, Santa Cruz
Biotechnology, Santa Cruz, CA) were used with a
peroxidase-based detection system (Vectastain Elite ABC,
Vector Labs, Burlingame, CA) and 3,3’ diaminobenzidine as

the substrate chromagen to detect protein localization. Nonimmune controls were performed without primary antibody.

E. Statistical Analysis
All data are presented as the mean standard deviation.
One- (vitamin D dose dependence), two-(monolayer and
noggin studies), or three-way (density dependence study)
ANOVAs with Tukey post-hoc tests were used to determine
the effect of vitamin D dose dependence, culture medium,
culture duration, and seeding density. Significance was set at
p < 0.05.

*

111. RESULTS

1) Vitamin D Dose-Dependence: Expression of alkaline
phosphatase activity normalized to DNA content showed a
dose-dependent response to vitamin D. Significant increases
in activity were observed when cells were cultured in the
presence of 10 and 100 nM vitamin D, with maximal
activity at 100 nM. Additionally, an increase in vitamin D to
1000 nM resulted in a decrease in activity to a level similar
to DMSO controls.
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Fig. 1 : Ostcoblast-spccific gcnc cxprcssion by human dcrmal fibroblast
cultures. Cells were cultured in S, S+vitD, I, or I+vitD medium. (A)
Alkaline phosphatase, (C) osteocalcin, and (D) osteopontin gene expression
were normalized to B-Actin. (€3) Alkaline phosphatase activity was
nomalizcd to DNA content. (a: p<0.05 comparcd to S, I cultures, *: p<0.05
compared to all culture conditions)

2) Monolayer Culture: Human dermal fibroblasts plated
in monolayer were analyzed at 7, 14, and 21 day time points
for gene expression, biochemistry, and histology. Alkaline
phosphatase, osteopontin, and osteocalcin were analyzed as
markers of osteoblastic gene expression. Alkaline
phosphatase (Fig 1A) was detected in all cultures with a
significant up-regulation observed over time. There was no
significant effect of culture medium on alkaline phosphatase
expression. Osteocalcin (Fig IC) was only observed in
cultures containing vitamin D, with a significant effect of
both culture duration and culture medium. Osteocalcin
expression was highest in cultures maintained in serum-free
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medium with vitamin D, with maximum expression at 21
days. Similar to osteocalcin, osteopontin (Fig 1D) was only
observed in cultures supplemented with vitamin D. Maximal
osteopontin expression was seen at 21 days.
Alkaline phosphatase activity normalized to DNA content
(Fig 1B) was elevated in monolayer cultures containing
vitamin D at both 14 and 21 days. This increase was
significantly greater in serum-free cultures compared to
those containing serum. Alkaline phosphatase staining was
observed in all cultures, with the highest levels of staining
detected in fibroblasts maintained in the presence of vitamin
D. However, a larger proportion of positively stained cells
was seen in the serum-free cultures. Fibroblasts cultured in
serum-free medium without supplements exhibited only
slight staining. The alkaline phosphatase staining patterns
were consistent with the activity data. Cellular morphology
was assessed by staining F-actin. Cells cultured in serumfree medium with vitamin D exhibited a more polygonal
shape, similar in shape to osteoblastic cells. The fibroblasts
cultured in serum-containing medium and in serum-free
medium without additional additives maintained an
elongated, spindle-shaped morphology, typical of
fibroblasts.

Treatment with noggin caused a down-regulation of
osteocalcin expression. BMP6 gene expression (Fig 2D) was
also only seen in samples containing vitamin D. Treatment
with noggin resulted in an increase in BMP6 gene
expression.
Alkaline phosphatase activity normalized to DNA content
(Fig 2B) was observed at low levels at the 3 day time point.
At 14 days, alkaline phosphatase activity was detected in all
cultures, with a significant increase in activity in cultures
containing vitamin D. Treatment with noggin resulted in a
decrease in alkaline phosphatase activity by approximately
47%.
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Fig. 3: (A) Alkaline phosphatase and (C) ostcocalcin gene expression and
(B) alkaline phosphatase activity of fibroblast-seeded scaffolds initially
seeded with 1.5 or 3.0 x IO6 cells and maintained in S or I+vitD medium.
Gene expression is shown relative to day 7 samples cultured in I+vitD
medium. (a: p<0.05 compared to S cultures, *: p<0.05 compared to all
culture conditions)

I+vitD+Noggin Medium
Fig. 2: (A) Alkaline phosphatase, (C) osteocalcin, and (D) BMP6 gene
expression and (B) alkaline phosphatase activity of human dermal
fibroblasts maintained in S, I+vitD, or I+vitD+Noggin medium. Gene
expression is shown relative to day 3 samples cultured in I+vitD medium.
(a: p<0.05 compared to S cultures, *: p<0.05 compared to all culture
conditions)

3) BMP Signaling: Dermal fibroblasts cultured in
monolayer and treated with noggin were analyzed at 3 and
14 days for alkaline phosphatase, osteocalcin, and BMP6
gene expression and alkaline phosphatase activity. Relative
gene expression was normalized to GAPDH and expressed
relative to the day 3 I+vitD samples. Alkaline phosphatase
gene expression (Fig 2A) was significantly up-regulated in
samples cultured with vitamin D, with decreased expression
when cultured in the presence of noggin. Control samples
exhibited low levels of expression of alkaline phosphatase.
Osteocalcin gene expression (Fig 2C) was only observed in
samples cultured in the presence of vitamin D at 14 days.

4) Three-Dimensional Culture Seeding Density: Analysis of
21 day samples seeded with initial densities of 0.5, 1.5, 3,
and 5 x lo6 cells showed osteoblastic gene expression only
in scaffolds cultured in I+vitD medium.
Alkaline
phosphatase gene expression (normalized to GAPDH) was
approximately 40% higher in scaffolds seeded with 0.5 and
5.0 million cells compared to those seeded with 1.5 and 3
million cells, with no difference between 1.5 and 3 million
cells. Osteocalcin gene expression did not differ
significantly between
seeding densities.
Alkaline
phosphatase activity was significantly elevated in scaffolds
seeded with 1.5 million cells compared to all other groups.
DNA content was significantly increased in the scaffolds
seeded at higher initial seeding densities (1.5, 3, and 5.0),
with a maximum of approximately 800,000 attached cells at
initial seeding densities of 3 and 5 million cells/scaffold.
Taking into account gene expression, alkaline phosphatase
activity, and DNA content, seeding densities of 1.5 and 3
million cells were selected for further characterization.
Scaffolds seeded with 1.5 and 3 x 1O6 cells/scaffold were
analyzed at 7, 14, 21, and 28 days. Alkaline phosphatase
(Fig 3A) and osteocalcin (Fig 3C) gene expression were
significantly higher in scaffolds cultured in I+vitD medium
at all time points. There was no difference in gene
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expression between scaffolds initially seeded with 1.5 and
3.0 x 106 cells. Alkaline phosphatase activity (Fig 3B) was
significantly increased in the scaffolds seeded at 1.5 x lo6
cellsiscaffold at the 21 and 28 day time points. Staining for
alkaline phosphatase and osteocalcin supported the gene
expression and activity results, with the most intense
staining in the scaffolds seeded at the lower initial density.
IV. CONCLUSION
These studies indicate that dermal fibroblasts cultured in
chemically-defined medium supplemented with 1a,25dihydroxyvitamin D3 are able to express gene and protein
markers consistent with an osteoblastic phenotype. This
process appears to be partially blocked by noggin, indicating
a role of bone morphogenetic proteins in the osteoblastic
differentiation of these cells. Further studies are necessary to
elucidate the exact role of BMPs in this process. Taken
together, these results demonstrate that the combination of
dermal fibroblasts, p-tricalcium phosphate scaffolds, and
1a,25-dihydroxyvitamin D3 has potential for use in bone
tissue engineering applications.
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